Literature DB >> 8239057

A botanical compound, Padma 28, increases walking distance in stable intermittent claudication.

H Drabaek1, J Mehlsen, H Himmelstrup, K Winther.   

Abstract

Thirty-six patients with a median age of sixty-seven years and a median duration of intermittent claudication of five years were randomized to either active treatment with Padma 28 or placebo. The effect of treatment was quantified by measurements of systemic and peripheral systolic blood pressures and by measurements of the pain-free and the maximal walking distance on a treadmill. The ankle pressure index (ankle systolic pressure/arm systolic pressure) was calculated. The group randomized to active treatment received two tablets bid containing 340 mg of a dried herbal mixture composed according to an ancient lamaistic preparation (Padma 28). After active treatments, administered over a period of four months in a double-blinded, randomized design, the patients allocated to this group attained a significant increase in the pain-free walking distance from 52 m (20-106) to 86 m (24-164; P < 0.05) and in the maximal walking distance from 115 m (72-218) to 227 m (73- > 1,000; P < 0.05). The patient-group receiving placebo treatments did not show any significant changes in either the painfree or the maximal walking distance. The authors could not demonstrate any significant changes in the ankle pressure index either during active or during placebo treatment. In conclusion, this study has shown that treatment with Padma 28 over a period of four months significantly increased the walking distance in patients with stable, intermittent claudication of long duration.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8239057     DOI: 10.1177/000331979304401103

Source DB:  PubMed          Journal:  Angiology        ISSN: 0003-3197            Impact factor:   3.619


  4 in total

1.  Amelioration of hepatic fibrosis via Padma Hepaten is associated with altered natural killer T lymphocytes.

Authors:  I Ginsburg; E Koren; A Horani; M Mahamid; S Doron; N Muhanna; J Amer; R Safadi
Journal:  Clin Exp Immunol       Date:  2009-07       Impact factor: 4.330

2.  PADMA-28, a traditional tibetan herbal preparation inhibits the respiratory burst in human neutrophils, the killing of epithelial cells by mixtures of oxidants and pro-inflammatory agonists and peroxidation of lipids.

Authors:  I Ginsburg; M Sadovnik; S Sallon; I Milo-Goldzweig; R Mechoulam; A Breuer; D Gibbs; J Varani; S Roberts; E Cleator; N Singh
Journal:  Inflammopharmacology       Date:  1999       Impact factor: 4.473

3.  Apoptosis induced by the Tibetan herbal remedy PADMA 28 in the T cell-derived lymphocytic leukaemia cell line CEM-C7H2.

Authors:  Marcel Jenny; Wolfgang Schwaiger; David Bernhard; Oliver A Wrulich; Daria Cosaceanu; Dietmar Fuchs; Florian Ueberall
Journal:  J Carcinog       Date:  2005-09-02

4.  Pathway-focused bioassays and transcriptome analysis contribute to a better activity monitoring of complex herbal remedies.

Authors:  Angela Klein; Oliver A Wrulich; Marcel Jenny; Peter Gruber; Kathrin Becker; Dietmar Fuchs; Johanna M Gostner; Florian Uberall
Journal:  BMC Genomics       Date:  2013-02-27       Impact factor: 3.969

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.